In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment | bioRxiv
Pharmaceutical Cocrystals of Niclosamide | Crystal Growth & Design
Frontiers | The magic bullet: Niclosamide
Niclosamide, STAT3 inhibitor (CAS 50-65-7) (ab120868) | Abcam
Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway | PLOS ONE
Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis - ScienceDirect
Niclosamide causes lysosome-dependent cell death in endometrial cancer cells and tumors. - ScienceDirect
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential | ACS Infectious Diseases
Frontiers | Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis
N-substituted phenylbenzamides of the niclosamide chemotype attenuate obesity related changes in high fat diet fed mice | PLOS ONE
Using Salt Cocrystals to Improve the Solubility of Niclosamide | Crystal Growth & Design
Frontiers | Niclosamide Blocks Rice Leaf Blight by Inhibiting Biofilm Formation of Xanthomonas oryzae
Frontiers | Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification
StudyPages - Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer
In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment | bioRxiv
CAS Number 50-65-7 | Niclosamide
Niclosamide Exposure at Environmentally Relevant Concentrations Efficaciously Inhibited the Growth and Disturbed the Liver-Gut Axis of Adult Male Zebrafish | Environmental Science & Technology
Frontiers | Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways
Vaccines | Free Full-Text | In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment
Pharmaceuticals | Free Full-Text | Combination of Niclosamide and Pirfenidone Alleviates Pulmonary Fibrosis by Inhibiting Oxidative Stress and MAPK/Nf-κB and STATs Regulated Genes
Niclosamide activates the NLRP3 inflammasome by intracellular acidification and mitochondrial inhibition | Communications Biology
Frontiers | The magic bullet: Niclosamide
Migration and Transformation Characteristics of Niclosamide in a Soil–Plant System | ACS Omega
Frontiers | Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
Frontiers | The magic bullet: Niclosamide
Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection - ScienceDirect
Frontiers | Niclosamide does not modulate airway epithelial function through blocking of the calcium activated chloride channel, TMEM16A
